Artelo Biosciences, Inc. (ARTL) completed a public offering of 640,924 shares of common stock at $4.40 per share and pre-funded warrants for 40,894 shares at $4.399 each, raising approximately $3 million in gross proceeds before expenses. Underwriters have a 45-day option to purchase up to 102,272 additional shares. R. F. Lafferty & Co., Inc. acted as the sole book-running manager and underwriter. The securities were issued under Artelo’s effective shelf registration statement. ARTL closed at $4.51 on Friday, up 3.68% on NasdaqCM with no after-hours movement.

Read more at Nasdaq: Artelo Biosciences Closes $3 Mln Public Offering Of Common Stock And Pre-Funded Warrants